“…For all 34 studies combined (n=28,494), FEV 1 /FVC was 1.5% [95% CI= −1.9 to −1.2%] lower among overweight/obese subjects 12, 15–18, 23–29, 31, 34, 35, 38, 40, 45, 47, 48, 50, 53, 55, 57, 59, 61–63, 66–71 (Table 1). The decrement was more pronounced in children (−2.4%, [95% CI= −3.0 to −1.8%]) than in adults (−1.0% [95% CI= −1.4 to −0.6%]) (Figure 4); and it was similar in subjects with (−1.5% [95% CI= −1.9 to −1.0%]) and without asthma (−1.6% [95% CI= −2.3 to −0.8%]) (Table 1).…”